Second U.S. judge blocks Trump administration birth control rules
By Nate Raymond (Reuters) – A federal judge in Pennsylvania on Monday blocked the Trump...
Read More
Updated
U.S. lawmaker launches investigation into pharma drug pricing
By Yasmeen Abutaleb WASHINGTON (Reuters) – A top U.S. lawmaker launched an investigation...
Read MoreU.S. substance abuse helpline largely unknown
By Linda Carroll (Reuters Health) – The U.S. government’s toll-free substance abuse helpline, which provides free referral services to those looking for treatment, gets little publicity, a new study finds. By...
Read More
France to cull wild boar at Belgium border in swine fever alert
PARIS (Reuters) – France will cull all wild boar in a zone along the Belgian border to try...
Read MoreU.S. judge partially blocks Trump administration birth control rules
By Jan Wolfe (Reuters) – A judge in California on Sunday partially blocked a set of Trump administration rules that allow employers to opt out of providing health insurance that covers women’s birth control from...
Read More
Fund battling AIDS, TB and malaria seeks $14 billion to invigorate fight
By Kate Kelland LONDON, Jan 11 (Reuters) – At least $14 billion is needed to accelerate the...
Read More
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy
By Deena Beasley (Reuters) – Eli Lilly and Co remains in the hunt for cancer drugs even...
Read More
Up to 84,000 Americans hospitalized with flu in past three months: CDC
(Reuters) – An estimated 69,000 to 84,000 Americans were hospitalized due to the flu in the...
Read More
China could lift life expectancy by nearly three years if it meets WHO smog standards: study
BEIJING/SHANGHAI (Reuters) – China could raise average life expectancy by 2.9 years if it...
Read More
J&J raises U.S. prices on around two dozen drugs
By Michael Erman NEW YORK (Reuters) – Johnson & Johnson raised U.S. prices on around two...
Read More
Sen. Sanders, Rep. Cummings introduce bill to lower U.S. drug prices
By Yasmeen Abutaleb WASHINGTON (Reuters) – U.S. Senator Bernie Sanders and Representative...
Read MoreAkorn gets FDA warning letter for Illinois plant, shares drop
(Reuters) – Akorn Inc said on Wednesday it received a warning letter from the U.S. Food and Drug Administration following an inspection of the company’s Decatur, Illinois manufacturing plant last year. Shares of the...
Read More
New York City launches $100 million universal health insurance program
By Gina Cherelus NEW YORK (Reuters) – New York City has launched a $100 million health...
Read More
Latest trial in J&J talc litigations gets under way in California
By Tina Bellon (Reuters) – A California jury on Monday heard opening statements in the...
Read More
New California governor tackles drug prices in first act
By Sharon Bernstein (Reuters) – Hours into his new job, California Governor Gavin Newsom...
Read More
Chinese scientist criticized for risking ‘gene-edited’ babies’ lives
By Kate Kelland, Health and Science Correspondent LONDON, Jan 7 (Reuters) – A leading...
Read More
U.S. top court rejects Amgen over cholesterol medication patent fight
By Jan Wolfe WASHINGTON (Reuters) – Amgen Inc on Monday lost its bid at the U.S. Supreme...
Read More
U.S. Supreme Court could side with Merck over Fosamax lawsuits
By Andrew Chung WASHINGTON (Reuters) – U.S. Supreme Court justices on Monday appeared...
Read More
AstraZeneca picks Baselga to lead oncology R&D in growth plan
By Noor Zainab Hussain and Arathy S Nair (Reuters) – AstraZeneca said on Monday it had hired...
Read More
Merck loses bid to revive $200 million Gilead verdict at U.S. high court
By Jan Wolfe WASHINGTON (Reuters) – The U.S. Supreme Court on Monday handed a defeat to...
Read More